ES3001104T3 - Acido (1R,3S)-3-((5-ciano-4-feniltiazol-2-il)carbamoil)ciclopentano-1-carboxílico y derivados del mismo para su uso en el tratamiento de enfermedades de las vías respiratorias - Google Patents
Acido (1R,3S)-3-((5-ciano-4-feniltiazol-2-il)carbamoil)ciclopentano-1-carboxílico y derivados del mismo para su uso en el tratamiento de enfermedades de las vías respiratorias Download PDFInfo
- Publication number
- ES3001104T3 ES3001104T3 ES21765908T ES21765908T ES3001104T3 ES 3001104 T3 ES3001104 T3 ES 3001104T3 ES 21765908 T ES21765908 T ES 21765908T ES 21765908 T ES21765908 T ES 21765908T ES 3001104 T3 ES3001104 T3 ES 3001104T3
- Authority
- ES
- Spain
- Prior art keywords
- compound
- treatment
- asthma
- use according
- subjects
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20382764.7A EP3957308A1 (en) | 2020-08-21 | 2020-08-21 | (1r,3s)-3-((5-cyano-4-phenylthiazol-2-yl)carbamoyl)cyclopentane-1-carboxylic acid and derivatives thereof for use in the treatment of airway diseases |
| PCT/EP2021/073133 WO2022038261A1 (en) | 2020-08-21 | 2021-08-20 | (1r,3s)-3-((5-cyano-4-phenylthiazol-2-yl)carbamoyl)cyclopentane-1-carboxylic acid and derivatives thereof for use in the treatment of airway diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES3001104T3 true ES3001104T3 (es) | 2025-03-04 |
Family
ID=72234795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES21765908T Active ES3001104T3 (es) | 2020-08-21 | 2021-08-20 | Acido (1R,3S)-3-((5-ciano-4-feniltiazol-2-il)carbamoil)ciclopentano-1-carboxílico y derivados del mismo para su uso en el tratamiento de enfermedades de las vías respiratorias |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20230321053A1 (https=) |
| EP (2) | EP3957308A1 (https=) |
| JP (1) | JP7794807B2 (https=) |
| KR (1) | KR20230054444A (https=) |
| CN (1) | CN115942933A (https=) |
| AU (1) | AU2021327728A1 (https=) |
| BR (1) | BR112023002778A2 (https=) |
| CA (1) | CA3190081A1 (https=) |
| DK (1) | DK4199922T3 (https=) |
| ES (1) | ES3001104T3 (https=) |
| FI (1) | FI4199922T3 (https=) |
| HR (1) | HRP20241621T1 (https=) |
| HU (1) | HUE069338T2 (https=) |
| LT (1) | LT4199922T (https=) |
| MX (1) | MX2023002156A (https=) |
| PL (1) | PL4199922T3 (https=) |
| PT (1) | PT4199922T (https=) |
| RS (1) | RS66263B1 (https=) |
| SI (1) | SI4199922T1 (https=) |
| WO (1) | WO2022038261A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102460040B1 (ko) | 2016-04-27 | 2022-11-01 | 애브비 인코포레이티드 | 항-il-13 항체를 이용한 il-13 활성이 유해한 질환의 치료 방법 |
| US12162940B2 (en) | 2021-05-05 | 2024-12-10 | Immatics Biotechnologies Gmbh | BMA031 antigen binding polypeptides |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070219223A1 (en) | 2006-03-07 | 2007-09-20 | Endacea, Inc. | Compositions and methods for treating respiratory disorders |
| ES2331220B1 (es) | 2007-10-02 | 2010-09-23 | Palobiofarma, S.L. | Nuevos compuestos como antagonistas de los receptores a1 de adenosina. |
| KR20160061352A (ko) | 2013-10-15 | 2016-05-31 | 메디뮨 엘엘씨 | 벤랄리주맙을 사용하여 만성 폐쇄성 폐 질환을 치료하는 방법 |
| UA122670C2 (uk) * | 2014-09-08 | 2020-12-28 | Сефалон, Інк. | Спосіб лікування еозинофільної астми у пацієнта |
| ES2676535B1 (es) * | 2017-01-20 | 2019-04-29 | Palobiofarma Sl | Moduladores de los receptores a3 de adenosina |
| LT3592734T (lt) | 2017-03-06 | 2021-07-26 | Palobiofarma, S.L. | (1r,3s)-3-(5-ciano-4-fenil-1,3-tiazol-2-ilkarbamoil)ciklopentankarboksirūgšties amino druska |
-
2020
- 2020-08-21 EP EP20382764.7A patent/EP3957308A1/en not_active Withdrawn
-
2021
- 2021-08-20 RS RS20241285A patent/RS66263B1/sr unknown
- 2021-08-20 CA CA3190081A patent/CA3190081A1/en active Pending
- 2021-08-20 MX MX2023002156A patent/MX2023002156A/es unknown
- 2021-08-20 PL PL21765908.5T patent/PL4199922T3/pl unknown
- 2021-08-20 HU HUE21765908A patent/HUE069338T2/hu unknown
- 2021-08-20 FI FIEP21765908.5T patent/FI4199922T3/fi active
- 2021-08-20 DK DK21765908.5T patent/DK4199922T3/da active
- 2021-08-20 AU AU2021327728A patent/AU2021327728A1/en active Pending
- 2021-08-20 KR KR1020237009717A patent/KR20230054444A/ko active Pending
- 2021-08-20 CN CN202180051106.2A patent/CN115942933A/zh active Pending
- 2021-08-20 HR HRP20241621TT patent/HRP20241621T1/hr unknown
- 2021-08-20 LT LTEPPCT/EP2021/073133T patent/LT4199922T/lt unknown
- 2021-08-20 US US18/040,508 patent/US20230321053A1/en active Pending
- 2021-08-20 WO PCT/EP2021/073133 patent/WO2022038261A1/en not_active Ceased
- 2021-08-20 BR BR112023002778A patent/BR112023002778A2/pt unknown
- 2021-08-20 PT PT217659085T patent/PT4199922T/pt unknown
- 2021-08-20 EP EP21765908.5A patent/EP4199922B1/en active Active
- 2021-08-20 ES ES21765908T patent/ES3001104T3/es active Active
- 2021-08-20 JP JP2023512647A patent/JP7794807B2/ja active Active
- 2021-08-20 SI SI202130242T patent/SI4199922T1/sl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20230321053A1 (en) | 2023-10-12 |
| EP3957308A1 (en) | 2022-02-23 |
| RS66263B1 (sr) | 2024-12-31 |
| JP2023538419A (ja) | 2023-09-07 |
| EP4199922B1 (en) | 2024-09-25 |
| DK4199922T3 (da) | 2024-11-25 |
| SI4199922T1 (sl) | 2025-03-31 |
| HRP20241621T1 (hr) | 2025-01-31 |
| KR20230054444A (ko) | 2023-04-24 |
| PT4199922T (pt) | 2024-12-18 |
| BR112023002778A2 (pt) | 2023-03-14 |
| LT4199922T (lt) | 2025-01-10 |
| AU2021327728A1 (en) | 2023-03-09 |
| JP7794807B2 (ja) | 2026-01-06 |
| CA3190081A1 (en) | 2022-02-24 |
| FI4199922T3 (fi) | 2024-12-05 |
| HUE069338T2 (hu) | 2025-02-28 |
| WO2022038261A1 (en) | 2022-02-24 |
| EP4199922A1 (en) | 2023-06-28 |
| MX2023002156A (es) | 2023-03-01 |
| CN115942933A (zh) | 2023-04-07 |
| PL4199922T3 (pl) | 2025-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2645368T3 (es) | Terapias para mejorar la función pulmonar | |
| US20220152057A1 (en) | Methods and compositions for treating various disorders | |
| Krouse et al. | Asthma and the unified airway | |
| Ohta et al. | Japanese guideline for adult asthma | |
| US9815894B2 (en) | Use of reslizumab to treat moderate to severe eosinophilic asthma | |
| Fujimura et al. | Prostanoids and cough response to capsaicin in asthma and chronic bronchitis | |
| ES3001104T3 (es) | Acido (1R,3S)-3-((5-ciano-4-feniltiazol-2-il)carbamoil)ciclopentano-1-carboxílico y derivados del mismo para su uso en el tratamiento de enfermedades de las vías respiratorias | |
| CN115605201A (zh) | 血管紧张素ii 2型受体激动剂的新用途 | |
| CN116419746A (zh) | 右旋普拉克索用于治疗中度至重度哮喘的用途 | |
| Howe et al. | Audit of nasal lysine aspirin therapy in recalcitrant aspirin exacerbated respiratory disease | |
| JP2020530026A (ja) | 線維性疾患の治療における使用のための化合物及びその医薬組成物 | |
| US11160814B1 (en) | Methods of treatment for disease from coronavirus exposure | |
| ES2779762T3 (es) | Tratamiento de la alopecia areata | |
| HK40091313A (en) | (1r,3s)-3-((5-cyano-4-phenylthiazol-2-yl)carbamoyl)cyclopentane-1-carboxylic acid for use in the treatment of airway diseases | |
| HK40091313B (en) | (1r,3s)-3-((5-cyano-4-phenylthiazol-2-yl)carbamoyl)cyclopentane-1-carboxylic acid for use in the treatment of airway diseases | |
| Weldon | Gastroesophageal reflux disease and sinusitis: Their role in patients with chronic cough. | |
| EA048711B1 (ru) | (1r,3s)-3-((5-циано-4-фенилтиазол-2-ил)карбамоил)циклопентан-1-карбоновая кислота и ее производные для применения в лечении заболеваний дыхательных путей | |
| TW202237078A (zh) | 使用德弗米司特(devimistat)治療肉瘤之治療方法及組合物 | |
| JP2022515615A (ja) | 慢性炎症性腸疾患の治療のためのｐａｒ－１アンタゴニストの使用 | |
| CN119546306A (zh) | 施用贝舒地尔以治疗慢性移植物抗宿主病的方法 | |
| US20220054509A1 (en) | Methods of treatment for disease from coronavirus exposure | |
| WO2026007876A1 (zh) | Gpr84拮抗剂的用途 | |
| HK40090654A (zh) | 右旋普拉克索用於治疗中度至重度哮喘的用途 |